Kinetic analysis of a general model of activation of aspartic proteinase zymogens involving a reversible inhibitor. I. Kinetic analysis

References

• Manjabacas MC, Valero E, Garcia-Moreno M, Varon R. Kinetic analysis of an autocatalytic process coupled to a reversible inhibition. The inhibition of the system trypsinogen-trypsin by p-aminobenzamidine. Biol Chem Hoppe-Seyler 1995; 376: 577–580
   PubMed Web of Science ®Google Scholar
• Liu JH, Wang ZX. Kinetic analysis of ligand-induced autocatalytic reactions. Biochem J 2004; 379: 697–702
   PubMed Web of Science ®Google Scholar
• Al-Janabi J, Hartsuck JA, Tang J. Kinetics and mechanism of pepsinogen activation. J Biol Chem 1972; 247: 4628–4632
   PubMed Web of Science ®Google Scholar
• Richter C, Tanaka T, Yada RY. Mechanism of activation of the gastric aspartic proteinases: Pepsinogen, progastricsin and prochymosin. Biochem J 1998; 335: 481–490
   PubMed Web of Science ®Google Scholar
• Fuentes ME, Varon R, Garcia-Moreno M, Valero E. Kinetics of intra- and intermolecular zymogen activation with formation of an enzyme-zymogen complex. FEBS J 2005a; 272: 85–96
   PubMed Web of Science ®Google Scholar
• Fuentes ME, Varon R, Garcia-Moreno M, Valero E. Kinetics of autocatalytic zymogen activation measured by a coupled reaction: pepsinogen autoactivation. Biol Chem 2005b; 386: 689–698
   PubMed Web of Science ®Google Scholar
• Magklara A, Mellati AA, Wasney GA, Little SP, Sotiropoulou G, Becker GW, Diamandis EP. Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors. Biochem Biophys Res Commun 2003; 307: 948–955
   PubMed Web of Science ®Google Scholar
• Shariat-Madar Z, Mahdi F, Schmaier AH. Recombinant prolylcarboxypeptidase activates plasma prekallikrein. Blood 2004; 103: 4554–4561
   PubMed Web of Science ®Google Scholar
• Wolff AM, Din N, Petersen GL. Vacuolar and extracellular maturation of Saccharomyces cerevisae proteinase A. Yeast 1996; 12: 823–832
   PubMed Web of Science ®Google Scholar
• van den Hazel HB, Wolff AM, Kielland-Brandt MC, Winther JR. Mechanism and ion-dependence of in vitro autoactivation of yeast proteinase A: Possible implications for compartmentalized activation in vivo. Biochem J 1997; 326: 339–344
   PubMed Web of Science ®Google Scholar
• Kuroyanagi M, Nishimura M, Hara-Nishimura I. Activation of arabidopsis vacuolar processing enzyme by self-catalytic removal of an auto-inhibitory domain of the C-terminal propeptide. Plant Cell Physiol 2002; 43: 143–151
   PubMed Web of Science ®Google Scholar
• Hartley BS. Proteolytic enzymes. Annu Rev Biochem 1960; 29: 45–72
   PubMed Web of Science ®Google Scholar
• Baudy M, Pichová I, Pohl J, Kosta V. In: Aspartic proteinases and their inhibitors, V Kostka. Walter De Gruyter, Berlin 1985; 309–318
   Google Scholar
• Fujiwara S, Kunugi S, Oyama H, Oda K. Effects of pressure on the activity and spectroscopic properties of carboxyl proteinases. Apparent correlation of pepstatin-insensitivity and pressure reponse. Eur J Biochem 2001; 268: 645–655
   PubMedGoogle Scholar
• Dunn BM, Goodenow MM, Gustchina A, Wlodawer A. Retroviral proteases. Genome Biol 2002, 3: REVIEWS3006.1-REVIEWS30067
   PubMed Web of Science ®Google Scholar
• Barrett AJ, Rawlings ND, Woessner JF. Handbook of proteolytic enzymes2^nd ed,. Elsevier Academic Press, London 2004
   Google Scholar
• Tyndall JDA, Nall T, Fairlie P. Proteases universally recognized beta strands in their active sites. Chem Rev 2005; 105: 973–999
   PubMed Web of Science ®Google Scholar
• Dreyer T, Valler MJ, Kay J, Charlton P, Dunn BM. The selectivity of action of the aspartic-proteinase inhibitor IA3 from yeast (saccharomyces-cervisiae). Biochem J 1985; 231: 777–779
   PubMed Web of Science ®Google Scholar
• Davies DR. The structure and function of the aspartic proteinases. Annu Rev Biophys Chem 1990; 19: 189–215
   PubMedGoogle Scholar
• Borg-von Zeppelín M, Meyer I, Thomssen R, Wurzner R, Sanglard D, Telenti A, Monod M. HIV-inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Dermatol 1999; 113: 747–751
   PubMed Web of Science ®Google Scholar
• McPhie P. Spectrophotometric investigation of pepsinogen-pepsin conversion. J Biol Chem 1972; 247: 4277–4381
   PubMed Web of Science ®Google Scholar
• Richter C, Tanaka T, Koseki RY, Yada RY. Contribution of a prosegment lysine residue to the function and structure of porcine pepsinogen A and its active form pepsin A. Eur J Biochem 1999; 261: 746–752
   PubMedGoogle Scholar
• Varon R, Fuentes M, Garcia-Moreno M, Garcia-Sevilla F, Arias E, Valero E, Arribas E. Contribution of the intra- and intermolecular routes in autocatalytic zymogen activation: Application to pepsinogen activation. Acta Biochim Pol 2006a; 53: 407–420
   PubMed Web of Science ®Google Scholar
• Varon R, Garcia-Moreno M, Valera-Ruiperez D, Garcia-Molina F, Garcia-Canovas F, Ladron-de Guevara RG, Masia-Perez J, Havsteen BH. Kinetic analysis of a general model of activation of aspartic proteinase zymogens. J Theor Biol 2006, In press
   Web of Science ®Google Scholar
• Isahara K, Ohsawa Y, Kanamori S, Shibata M, Waguri S, Sato N, Gotow T, Watanabe T, Mornoi T, Urase K, Kominami E, Uchiyama Y. Regulation of a novel pathway for cell death by lisozomal aspartic and cysteine proteinases. Neurosci 1999; 91: 233–249
   PubMed Web of Science ®Google Scholar
• Tossi A, Bonin I, Antcheva N, Norbedo S, Benedetti F, Miertus S, Nair AC, Maliar T, Dal Bello F, Palù G, Romeo D. Aspartic protease inhibitors an integrated approach for the design and synthesis of diaminodiol-based peptidomimetics. Eur J Biochem 2000; 267: 1715–1722
   PubMedGoogle Scholar
• Bartoglio B, Golde TE. Intramembrane-cleaving aspartic proteases and disease: Presenilins, signal peptide peptidase and their homologs. Human Mol Gen 2003; 12: R201–R206
   PubMed Web of Science ®Google Scholar
• Xia Y, Suzuki H, Borevitz J, Blount J, Guo Z, Patel K, Dixon RA, Lamb C. An extracellular aspartic protease functions in arabidopsis disease resistance signaling. The EMBO J 2004; 23: 980–988
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman HM, Kimura T, Hidaka K, Kiso A, Nezami A, Freire E, Hayashi Y, Kiso Y. Design of inhibitors against HIV, HTLV-I and Plasmodium falciparum aspartic proteases. Bio Chem 2004; 385: 1035–1039
   PubMed Web of Science ®Google Scholar
• Ersmark K, Nervall M, Hamelink E, Janka LK, Clemente JC, Dunn BM, Blackman MJ, Samuelsson B, Aqvist J, Hallberg A. Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulations. J Med Chem 2005; 48: 6090–6106
   PubMed Web of Science ®Google Scholar
• Liu J, Istvan ES, Gluzman IY, Gross J, Goldberg DE. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. Proc Natl Acad Sci USA 2006; 103: 8840–8845
   PubMed Web of Science ®Google Scholar
• Ueno E, Sakai H, Kato Y, Yamamoto K. Activation Mechanism of Erythrocyte Cathepsin E. Evidence for the Occurrence of the Membrane-Associated Active Enzyme. J Biochem 1989; 105: 878–882
   PubMed Web of Science ®Google Scholar
• Navia MA, Fitzgerald PMD, Mckeever BM, Leu CT, Heimbach JC, Herber WK, Sigal IS, Darke PL, Springer JP. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature 1989; 337: 615–620
   PubMed Web of Science ®Google Scholar
• Farley PC, Christeller JT, Sullivan ME, Sullivan PA, Laing W. A Analysis of the interaction between the aspartic peptidase inhibitor SQAPI and aspartic peptidases using surface plasmon resonance. J Mol Recognition 2002; 15: 135–144
   PubMed Web of Science ®Google Scholar
• Llido S, d'Estaintot BL, Daudant A, Geoffre S, Picard P, Precigoux G. Conformational study of a putative HLTV-1 retroviral protease inhibitor. Acta Cryst D 1993; 49: 344–348
   PubMedGoogle Scholar
• Zollner H. Handbook of enzyme inhibitors2nd ed,. VCH, Weinheim 1993
   Google Scholar
• Benyon RJ, Bond J. S Proteolytic Enzymes: A Practical Approach, Eds, pp. 241–249. 1994.
   Google Scholar
• Fehlberg E, Runge-Kutta K. Formeln vierter und niedrigerer Ordnung mit Schrittweiten-Kontrolle und ihre Anwendung auf Wärmeleitungsprobleme. Computing 1970; 6: 61–71
   Web of Science ®Google Scholar
• , Mathews JH, Fink KD. Ecuaciones diferenciales ordinarias. Métodos numéricos con MATLAB 3a ed., pp.505–509, Madrid, España. 1999.
   Google Scholar
• Garcia-Sevilla F, Garrido del Solo C, Duggleby RG, Garcia-Cánovas F, Peyro R, Varon R. Use of a windows program for simulation of the progress curves of ractans and intermediates envolved enzyme-catalysed reactions. Biosystems 2000; 54: 151–164
   PubMed Web of Science ®Google Scholar
• Dixon M, Webb EC, Thorne CJR, Tipton KF. Enzymes3rd. Ed. Longman, London 1979; 300–307
   Google Scholar
• Garcia-Moreno M, Havsteen BH, Varon R, Rix-Matzen H. Evaluation of the kinetic parameters of the activation of trypsinogen by trypsin. Biochim Biophys Acta 1991; 1080: 143–147
   PubMed Web of Science ®Google Scholar
• Manjabacas MC, Valero E, García-Moreno M, García-Cánovas F, Rodríguez JN, Varón R. Kinetic analysis of the control through inhibition of autocatalytic zymogen activation. Biochem J 1992; 282: 583–587, 470
   PubMed Web of Science ®Google Scholar
• Manjabacas MC, Valero E, García Moreno M, Varón R. Kinetic analysis of an autocatalytic process coupled to a reversible inhibition. The inhibition of system trypsinogen-trypsin by p-aminobenzamidine. Biol Chem Hoppe-Seyler 1995; 376: 577–580
   PubMed Web of Science ®Google Scholar